What is the most recent FDA action against Shimoga Chemicals?

The most recent FDA event Argus HQ has on file for Shimoga Chemicals is dated 2026-07-13, with a severity rating of "critical" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Shimoga Chemicals automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Shimoga Chemicals is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Shimoga Chemicals?

1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Shimoga Chemicals?

July 13, 2026. Argus HQ ingests new FDA enforcement records daily.

Shimoga Chemicals — FDA Enforcement History

FDA action counts

Total FDA actions	1
Warning letters	1
Recalls	0
Approval records	0
Form 483 inspection citations	0
Most recent action	July 13, 2026

In short: Argus HQ has recorded 1 FDA events for Shimoga Chemicals: 1 warning letters, 0 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-07-13 to 2026-07-13. The most severe rating Argus HQ has assigned across this history is "critical". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Shimoga Chemicals has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-07-13, Argus HQ recorded an FDA Warning Letter for Shimoga Chemicals, rated "critical" severity in Argus HQ's classification: Shimoga Chemicals — CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (2026-07-13). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

What is the most recent FDA action against Shimoga Chemicals?: The most recent FDA event Argus HQ has on file for Shimoga Chemicals is dated 2026-07-13, with a severity rating of "critical" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Does Argus HQ track new FDA actions for Shimoga Chemicals automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Shimoga Chemicals is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Shimoga Chemicals?: 1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Shimoga Chemicals?: July 13, 2026. Argus HQ ingests new FDA enforcement records daily.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Shimoga Chemicals — CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (2026-07-13) →

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Jul 13, 2026

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Shimoga Chemicals — FDA Enforcement History. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/shimoga-chemicals

MLA

"Shimoga Chemicals — FDA Enforcement History." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/shimoga-chemicals.

Chicago

Argus HQ Research. "Shimoga Chemicals — FDA Enforcement History." Digital Empire Holdings LLC. Accessed July 22, 2026. https://argushq.ai/company/shimoga-chemicals.

BibTeX

@misc{argushq_argushq_ai_company_shimoga_chemicals_2026,
  title = {Shimoga Chemicals — FDA Enforcement History},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/company/shimoga-chemicals},
  note = {Accessed: July 22, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗